These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2311809)

  • 41. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    Utian WH; Begg G; Vinik AI; Paul M; Shuman L
    Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginal bromocriptine in hyperprolactinemic patients and puerperal women.
    Jasonni VM; Raffelli R; de March A; Frank G; Flamigni C
    Acta Obstet Gynecol Scand; 1991; 70(6):493-5. PubMed ID: 1763616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dynamics of prolactin secretion during the puerperium in women.
    Vemer HM; Rolland R
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):155-63. PubMed ID: 6796300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromocriptine given orally to periparturient of lactating sows inhibits milk production.
    Farmer C; Robert S; Rushen J
    J Anim Sci; 1998 Mar; 76(3):750-7. PubMed ID: 9535334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years.
    Haase R; Jaspers C; Schulte HM; Lancranja I; Pfingsten H; Orri-Fend M; Reinwein D; Benker G
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):165-76. PubMed ID: 8435897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nasal spray vs oral administration of bromocriptine: pharmacology and effect on serum prolactin in puerperal women.
    Cicinelli E; Cignarelli M; Petruzzi D; Matteo MG; Ruccia C; Schonauer LM
    J Endocrinol Invest; 1996; 19(7):427-32. PubMed ID: 8884536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia.
    Wolf R
    Pharmacopsychiatry; 1992 Sep; 25(5):240-2. PubMed ID: 1357683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe cardiac dysrhythmia in patients using bromocriptine postpartum.
    Iffy L; O'Donnell J; Correia J; Hopp L
    Am J Ther; 1998 Mar; 5(2):111-5. PubMed ID: 10099047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lactation inhibition by the dopamine agonist CV 205-502.
    van der Heijden PF; Kremer JA; Brownell J; Rolland R
    Br J Obstet Gynaecol; 1991 Mar; 98(3):270-6. PubMed ID: 1673628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of puerperal lactation: A comparative study of bromocriptine and pyridoxine.
    Boes EG
    S Afr Med J; 1980 May; 57(22):900-3. PubMed ID: 6996132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of lactation comparing stilboestrol and bromocriptine (CB154).
    Ladipo OA; Ojo OA
    Niger Med J; 1979 Jan; 9(1):77-9. PubMed ID: 463344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum prolactin levels in women with excessive milk production. Normalization by transitory prolactin inhibition.
    Peters F; Geisthövel F; Breckwoldt M
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):463-6. PubMed ID: 3898690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation.
    Yuen BH; Pendleton HJ; Blair S
    Can Med Assoc J; 1977 Oct; 117(8):919-21. PubMed ID: 334356
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of lactation and season on plasma prolactin concentrations and response to bromocriptine during lactation in the Bennett's wallaby (Macropus rufogriseus rufogriseus).
    Curlewis JD; White AS; Loudon AS; McNeilly AS
    J Endocrinol; 1986 Jul; 110(1):59-66. PubMed ID: 3755462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of effect of methyl-ergonovine on postpartum lactation.
    Del Pozo E; Brun Del Re R; Hinselmann M
    Am J Obstet Gynecol; 1975 Dec; 123(8):845-6. PubMed ID: 1200082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine.
    Ciccarelli E; Miola C; Grottoli S; Avataneo T; Lancranjan I; Camanni F
    J Clin Endocrinol Metab; 1993 Feb; 76(2):484-8. PubMed ID: 8432794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The therapy of a macroprolactinoma with the intramuscular application of a long-acting bromocriptine preparation].
    Kreft B; Peters A; Kerner W
    Dtsch Med Wochenschr; 1996 Jul; 121(27):865-8. PubMed ID: 8681742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effect of prostaglandin F2alpha (PgF2alpha) on puerperal lactation.
    Fioretti P; Nasi A; Medda F; De Murtas M; Melis GB; Caminiti F
    Acta Eur Fertil; 1977 Sep; 8(3):265-71. PubMed ID: 920042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.